This inventor holds 1 USPTO granted patent and 4 EPO patents. Top assignee: Leo-Pharma A/s. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Søren Ebdrup: Innovator in Calcimimetic Compounds
Introduction
Søren Ebdrup is a notable inventor based in Roskilde, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of calcimimetic compounds. His work has led to advancements in the understanding and application of these compounds in therapeutic settings.
Latest Patents
Søren Ebdrup holds a patent for the polymorphic form of a calcimimetic compound. The patent, titled "Polymorphic form of a calcimimetic compound," describes the crystalline, polymorphic Form X of the compound {4-[(1R,3S)-3-((R)-1-Naphthalen-1-yl-ethylamino)-cyclopentyl]-phenoxy}-acetic acid. This invention details methods of preparation and characterization using techniques such as single crystal X-Ray crystallography, X-Ray Powder diffractometry, attenuated total reflectance Fourier transform infrared spectroscopy, Solid State NMR spectroscopy, and Differential Scanning Calorimetry. The patent also outlines the preparation of Form X through crystallization from a saturated solution or by precipitation from a neutralized saponification reaction mixture.
Career Highlights
Throughout his career, Søren has worked with prominent companies in the pharmaceutical industry, including Leo Pharma A/S and VTV Therapeutics LLC. His experience in these organizations has allowed him to contribute to various innovative projects and research initiatives.
Collaborations
Søren has collaborated with several professionals in his field, including Kim Troensegaard Nielsen and Tanja Maria Greve. These collaborations have fostered a productive environment for research and development in calcimimetic compounds.
Conclusion
Søren Ebdrup's contributions to the field of medicinal chemistry, particularly through his patent on calcimimetic compounds, highlight his role as an innovator. His work continues to influence the development of therapeutic applications in this area.
